Viewing StudyNCT00081926



Ignite Creation Date: 2024-05-05 @ 11:34 AM
Last Modification Date: 2024-10-26 @ 9:10 AM
Study NCT ID: NCT00081926
Status: COMPLETED
Last Update Posted: 2009-11-23
First Post: 2004-04-26

Brief Title: Gleevec Trial in Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia
Sponsor: Novartis Pharmaceuticals
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
Chronic Myelogenous Leukemia
Keywords:
Name View
CSTI571 View
CML View
Chronic Myelogenous Leukemia View
RIGHT Trial View
US177 View